We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Reinstates $235 Million Patent Judgment Against Teva
Appeals Court Reinstates $235 Million Patent Judgment Against Teva
Teva Pharmaceuticals is back on the hook for $235 million in damages for infringing on GlaxoSmithKline’s patent for its blood pressure drug Coreg (carvedilol), thanks to a federal appeals court ruling.